NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
23/01/2024
Voltar para busca
Dado oficial do USPTO
BIOINX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
21
Atualização mais recente
23/01/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 17, 42, 44
Data de depósito
21/04/2022
Data de registro
23/01/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/01/2024
Última transação
23/01/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
3
Tipo de titular
01
Localização do titular
Borchtlombeek, BE
Examinador
SALCIDO, JOHN CHARLES
Unidade examinadora
N40
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the word "BIO" in blue and "INX" in white. Behind the word "INX" is a figurative drop in various shades of blue from bright to dark.
Titulares e representantes
Titulares
Van Hoorick, Jasper
Representantes
Michael J. Hynak HYNAK & ASSOCIATES, PC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 17Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Polymer based compositions used in the field of 3D bioprinting; polymer dispersions for use in the field of 3D bioprinting for a wide variety of goods; Unprocessed polymer compounds for use in manufacture; chemical additives for use in the manufacture of food; chemical additives for use in the manufacture for a wide variety of goods in the biomedical and pharmaceutical fields; chemical preparations for scientific purposes in the biomedical and pharmaceutical fields; biological tissue cultures for industrial purposesother than for medical or veterinary purposes; biological tissue specimens for use in scientific research; collagen based ingredients used as a raw ingredient in the manufacture of cosmetic preparations; biological tissue cultures other than for medical or veterinary purposes; artificial skin for testing cosmetics; All of the aforesaid to be used in the field of 3D printing for biomedical applications
Classe 5
Tissue-regenerative pharmaceutical preparations for the treatment of damaged skin and tissue; natural biomaterials for augmentation of bone and tissue for medical purposes; cells for medical or clinical use; Polymer based materials for use in 3D bioprinting for medical use; biological preparations for the treatment of damaged skintissue and bonesskintissue and bone diseases; chemical preparations for pharmaceutical purposesthe treatment of damaged skintissuebonesskintissue and bone diseases; biological implantsa vital processed human or animal connective tissue; pharmaceutical implantsImplantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for the treatment of damaged skintissue and bonesskintissue and bone diseases
Classe 17
Semi-worked thermoplastic filaments used for 3d printing; semi-worked pla filaments for use in 3d printing; semi-worked abs filaments for use in 3d printing; plastic filaments for 3d printing
Classe 42
Medical research; laboratory research and testing services in the biomedical and pharmaceutical fields; conducting clinical trials for pharmaceutical products for others; drug discovery services; biomedical research services; pharmaceutical research and development
Classe 44
Regenerative medicine services
Publicações
Histórico de despachos e eventos da marca no USPTO.
21 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
23/01/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/11/2023
PUBO
PUBLISHED FOR OPPOSITION
07/11/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/10/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/10/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
04/10/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/10/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
04/10/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/10/2023
ALIE
ASSIGNED TO LIE
29/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/05/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
13/02/2023
GNRT
NON-FINAL ACTION E-MAILED
13/02/2023
CNRT
NON-FINAL ACTION WRITTEN
13/02/2023
DOCK
ASSIGNED TO EXAMINER
08/02/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
28/04/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/04/2022
NWAP
NEW APPLICATION ENTERED
25/04/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIOINX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.